Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Valneva Usa, Inc. (VALN) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Valneva Usa, Inc. (VALN) lobbying for?
Summary of lobbying data:
– Lobbying firms: Covington & Burling Llp, Valneva Usa, Llc), Tarplin, Inc., Milne, Llc, Wiener & Shofe Global Strategies (Fka M & W Government Affairs, Downs & Young
– General issues: Medical/Disease Research/Clinical Labs, Pharmacy, Budget/Appropriations, Health Issues
– Specific issues:
– Appropriations related to CDC report on arbovirus threat, vaccine access, Sec 2713)
– ACA coverage for all adult vaccines (Urging CMS to amend regulation related to Public Health Service Act, Amending regulation related to Public Health Service Act, Coverage of CDC recommended vaccines)
– Advocacy for inclusion of travelers vaccines to be designated by HHS as part of the routine vaccines available with no out of pocket expense
– Government agencies: Senate, House of Representatives
One could infer that Valneva Usa, Inc. is lobbying on issues related to medical research, clinical labs, and pharmacy in order to advance its goal of developing and marketing vaccines. The specific issues they lobbied on suggest that they are seeking funding for research on arbovirus threats and advocating for broader vaccine coverage under the Affordable Care Act. Additionally, they are advocating for inclusion of traveler vaccines as part of routine vaccines covered by insurance, which could potentially benefit their products in this area. It is likely that they are lobbying both the Senate and the House of Representatives in order to influence the legislative process and secure favorable policies and funding for their research and products.
